February 2, 2016
IDIBAPS takes part in the European HIV Vaccine Alliance (EHVA) to develop and evaluate new preventive and therapeutic vaccines. The European Commission grants with over 22 million euros in addition to the 6 million euros from Swiss Government. This effort is part of the European Commission Framework Programme for Research and Innovation (Horizon2020) and gathers together HIV leading scientists from 39 public institutions along with European, North American and African companies. Dr. Josep M. Gatell, head of the Infectious Diseases and AIDS IDIBAPS team, is the coordinator from this centre, and Drs. Felipe García, Montserrat Plana and Eloisa Yuste, researchers from the same group, also would join the project. The Spanish National Centre for Biotechnology of the CSIC (CNB-CSIC) also participates.
January 26, 2016
Researchers from Hospital Clínic, IDIBAPS, University of Barcelona (UB) and Mental Health Research Center (CIBERSAM), associated with Institute of Health Carlos III (ISCIII), have taken part in an international study, published in the prestigious journal The Lancet, where a region of the genome involved in the response to lithium in bipolar disorder has been discovered. This study is the largest genetic analysis using GWAS (Genome-Wide Association Study) carried out regarding the response to this medication so far and included data from more than 2,500 patients with the disease.
January 25, 2016
IDIBAPS and Fundació Clínic take part in EATRIS and ECRIN, two European Research Infrastructure Consortium
IDIBAPS and Fundació Clínic take part in two of the ERIC (European Research Infrastructure Consortium) consortiums promoted by the European Commission for the establishment and functioning of research infrastructure networks in the EU. These consortiums provide groups and research institutions services related to their activity and allow them to directly participate as members of European projects.
January 22, 2016
Researchers from the IIBB-CSIC and IDIBAPS have published an article in Oncotarget journal in which they have shown for the first time that diets enriched in two types of saturated fatty acids - palmitic and myristic - induce the development of steatohepatitis, an advanced stage of the fatty liver disease, and promotes fat to accumulate in the liver which causes inflammation. The coordinators of this study are Dr. Jose C. Fernández-Checa, Head of the Mitochondrial Regulation of Cell Death and Steatohepatitis IDIBAPS team, and Dr. Carmen García-Ruiz, researcher at the same team. Dr. Laura Martinez, post-doctoral researcher at Dr. Fernández-Checa’s group, is the first author of the study.
January 15, 2016
Dr. Jordi Bruix, Head of the hepatic Oncology Unit at Hospital Clínic de Barcelona, the Hepatic Oncology IDIBAPS research team, the Barcelona Clinic Liver Cancer (BCLC) and scientific director of CIBEREHD; Dr. Josep Dalmau, ICREA Professor and Head of the Pathogenesis of autoimmune neuronal disorders IDIBAPS research group; Dr. Josep Maria Llovet, ICREA Professor, Head of the Translational research in hepatic oncology research group at IDIBAPS and Director of Mount Sinai Liver Cancer Program at the Icahn School of Medicine at Mount Sinai (New York); and Dr. Eduard Vieta, head of the Psychiatry and Psychology Department at Hospital Clínic and leader of Bipolar Disorders team at IDIBAPS, are among the most influential names in science and appear in the Highly Cited Researchers 2015 list published by Thomson Reuters.